Pfizer Competitors & Alternatives
Pfizer competitors and alternatives include Eli Lilly and Company, Johnson & Johnson, etc.…
Jump
-
Stock
Price
-
Market
Cap
-
Employees
-
Income Statement
-
Revenue
-
Revenue by Product / Services
-
Revenue by Geography
-
Research and Development
-
Operating Income
-
Tax
Rate (%)
-
Net
Income
-
Assets & Liabilities | Cash Flow
-
Total Assets
-
Total Liabilities
-
Capital Expenditures (Capex)
-
Profitability
-
Operating Income Margin (%)
-
Net
Income Margin (%)
-
EBITDA
-
Free
Cash Flow (FCF)
-
Ratios
-
Return on Equity (ROE)
-
Return on Assets (ROA)
-
Debt
to Equity
-
Valuation
-
Enterprise value
-
Enterprise value to Revenue
-
Enterprise value to EBITDA
Ticker
PFE
LLY
JNJ
ABBV
Headquarter
New York City
,NY
US
US
Indianapolis
,IN
US
US
New Brunswick
,NJ
US
US
North Chicago
,IL
US
US
CEO
Albert Bourla
David A. Ricks
Joaquin Duato
Scott T. Reents
Industry
Drug Manufacturers - General
Drug Manufacturers - General
Drug Manufacturers - General
Drug Manufacturers - General
Stock Price
Stock Price
Market Cap
Market Cap
$157.21 B
$992.60 B
$598.69 B
$410.09 B
Employees
Years
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
Employees
- 88.00 K
- 81.00 K
- 75.00 K
- 43.00 K
- 47.00 K
- 200.00 K
- 131.90 K
- 138.10 K
- 138.20 K
- 50.00 K
- 55.00 K
- 57.00 K
Y/Y
6.02%
7.95%
7.41%
10.26%
9.3%
325.53%
13.62%
4.7%
0.07%
0%
10%
3.64%
Income Statement
Revenue
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Revenue
- $59.55 B
- $63.63 B
- $62.58 B
- $34.12 B
- $45.04 B
- $65.18 B
- $85.16 B
- $88.82 B
- $94.19 B
- $54.32 B
- $56.33 B
- $61.16 B
Y/Y
40.64%
6.84%
1.65%
19.56%
32%
44.7%
6.46%
4.3%
6.05%
6.44%
3.71%
8.57%
Revenue by Products / Services
Years
- 2025
- 2025
- 2025
- 2025
Revenue by Geography
Years
- 2025
- 2025
- 2025
- 2025
Research and Development
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Research and Development
- $10.58 B
- $10.74 B
- $11.98 B
- $9.31 B
- $10.99 B
- $13.34 B
- $15.09 B
- $17.23 B
- $14.67 B
- $7.68 B
- $12.79 B
- $9.10 B
Y/Y
7.42%
1.51%
11.53%
29.52%
18.01%
21.35%
6.72%
14.23%
14.9%
17.9%
66.66%
28.89%
Operating Income
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Operating Income
- $5.29 B
- $16.48 B
- $15.44 B
- $10.79 B
- $17.50 B
- $29.70 B
- $23.41 B
- $22.15 B
- $25.60 B
- $12.76 B
- $9.14 B
- $21.21 B
Y/Y
85.91%
211.47%
6.35%
24.66%
62.24%
69.67%
11.4%
5.38%
15.56%
29.59%
28.38%
132.18%
Tax Rate (%)
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Tax Rate (%)
- -105.29%
- -0.35%
- -3.54%
- 20.05%
- 16.49%
- 19.79%
- 11.53%
- 15.71%
- 17.73%
- 22.03%
- -15.34%
- 35.83%
Y/Y
1198.77%
99.67%
913.54%
143%
17.78%
20.04%
25.35%
36.28%
12.89%
81.94%
169.62%
333.62%
Net Income
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Net Income
- $2.13 B
- $8.02 B
- $7.77 B
- $5.24 B
- $10.59 B
- $20.64 B
- $35.15 B
- $14.07 B
- $26.80 B
- $4.86 B
- $4.28 B
- $4.23 B
Y/Y
93.2%
276%
3.12%
16.08%
102.08%
94.88%
95.94%
59.99%
90.56%
58.91%
12.03%
1.22%
Revenue Per Employee
Years
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
Revenue Per Employee
- $723.03 K
- $772.58 K
- -
- $1.05 M
- $1.39 M
- -
- $673.40 K
- $682.06 K
- -
- $1.13 M
- $1.11 M
- -
Y/Y
0.77%
6.85%
100%
19.72%
32.39%
100%
20.75%
1.29%
100%
3.71%
1.3%
100%
Net Income Per Employee
Years
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
- 2024
- 2025
- 2026
Net Income Per Employee
- $91.14 K
- $95.93 K
- -
- $246.28 K
- $439.11 K
- -
- $106.64 K
- $194.09 K
- -
- $85.56 K
- $76.84 K
- -
Y/Y
254.63%
5.26%
100%
83.29%
78.3%
100%
53.68%
82%
100%
12.03%
10.2%
100%
Assets & Liabilities | Cash Flow
Total Assets
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Total Assets
- $226.50 B
- $213.40 B
- -
- $64.01 B
- $78.71 B
- $112.48 B
- $167.56 B
- $180.10 B
- $199.21 B
- $134.71 B
- $135.16 B
- $5.46 B
Y/Y
14.86%
5.79%
100%
29.33%
22.98%
42.89%
10.58%
7.49%
10.61%
2.95%
0.33%
95.96%
Total Liabilities
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Total Liabilities
- $137.21 B
- $124.90 B
- -$93.10 B
- $53.14 B
- $64.44 B
- $85.94 B
- $98.78 B
- $108.61 B
- $117.67 B
- $124.31 B
- $131.80 B
- $26.29 B
Y/Y
35.47%
8.97%
174.54%
37.27%
21.26%
33.36%
10.66%
9.95%
8.33%
2.3%
6.02%
80.05%
Capital Expenditures (Capex)
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Capital Expenditures (Capex)
- -$3.91 B
- -$2.91 B
- -
- -$7.39 B
- -$8.40 B
- -$7.84 B
- -$4.54 B
- -$4.42 B
- -$4.83 B
- -$777.00 M
- -$974.00 M
- -
Y/Y
20.74%
25.54%
100%
147.62%
13.68%
6.69%
13.32%
2.62%
9.22%
11.8%
25.35%
100%
Profitability
Operating Income Margin (%)
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Operating Income Margin (%)
- 8.89%
- 25.91%
- 24.67%
- 31.61%
- 38.86%
- 45.56%
- 27.49%
- 24.94%
- 27.17%
- 23.49%
- 16.22%
- 34.69%
Y/Y
76.26%
191.53%
4.78%
4.27%
22.91%
17.26%
4.64%
9.28%
8.97%
24.74%
30.94%
113.86%
Net Income Margin (%)
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Net Income Margin (%)
- 3.58%
- 12.60%
- 12.42%
- 15.36%
- 23.51%
- 31.66%
- 41.28%
- 15.84%
- 28.46%
- 8.95%
- 7.59%
- 6.91%
Y/Y
88.54%
251.92%
1.49%
29.81%
53.1%
34.68%
84.04%
61.64%
79.69%
56.09%
15.18%
9.01%
EBITDA
| 2022 | 41031000000.00 |
|---|---|
| 2023 | 9557000000.00 |
| 2024 | 18127000000.00 |
| 2025 | 15097000000.00 |
| 2022 | 8660500000.00 |
|---|---|
| 2023 | 8567800000.00 |
| 2024 | 15227600000.00 |
| 2025 | 27936500000.00 |
| 2022 | 26605000000.00 |
|---|---|
| 2023 | 23320000000.00 |
| 2024 | 24781000000.00 |
| 2025 | 32581000000.00 |
| 2022 | 24174000000.00 |
|---|---|
| 2023 | 17172000000.00 |
| 2024 | 14910000000.00 |
| 2025 | 28293665000.00 |
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
EBITDA
- $9.56 B
- $18.13 B
- $15.10 B
- $8.57 B
- $15.23 B
- $27.94 B
- $23.32 B
- $24.78 B
- $32.58 B
- $17.17 B
- $14.91 B
- $28.29 B
Y/Y
76.71%
89.67%
16.72%
1.07%
77.73%
83.46%
12.35%
6.27%
31.48%
28.97%
13.17%
89.76%
Free Cash Flow (FCF)
| 2022 | 26031000000.00 |
|---|---|
| 2023 | 4793000000.00 |
| 2024 | 9835000000.00 |
| 2025 | 0.00 |
| 2022 | 4600400000.00 |
|---|---|
| 2023 | -3152000000.00 |
| 2024 | 414300000.00 |
| 2025 | 8972000000.00 |
| 2022 | 17185000000.00 |
|---|---|
| 2023 | 18248000000.00 |
| 2024 | 19842000000.00 |
| 2025 | 19698000000.00 |
| 2022 | 24248000000.00 |
|---|---|
| 2023 | 22062000000.00 |
| 2024 | 17832000000.00 |
| 2025 | 0.00 |
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Free Cash Flow (FCF)
- $4.79 B
- $9.84 B
- -
- -$3.15 B
- $414.30 M
- $8.97 B
- $18.25 B
- $19.84 B
- $19.70 B
- $22.06 B
- $17.83 B
- -
Y/Y
81.59%
105.2%
100%
168.52%
113.14%
2065.58%
6.19%
8.74%
0.73%
9.02%
19.17%
100%
Ratios
Return on Equity (ROE)
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Return on Equity (ROE)
- 2.40%
- 9.09%
- 8.35%
- 48.65%
- 74.62%
- 0.00%
- 51.11%
- 19.68%
- 0.00%
- 46.94%
- 128.66%
- 0.00%
Y/Y
92.69%
279.45%
8.21%
17.03%
53.38%
100%
118.81%
61.51%
100%
31.57%
174.1%
100%
Return on Assets (ROA)
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Return on Assets (ROA)
- 0.94%
- 3.76%
- 0.00%
- 8.19%
- 13.45%
- 0.00%
- 20.98%
- 7.81%
- 0.00%
- 3.61%
- 3.17%
- 0.00%
Y/Y
94.08%
299.09%
100%
35.12%
64.32%
100%
119.11%
62.77%
100%
57.66%
12.32%
100%
Debt to Equity
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Debt to Equity
- 79.59%
- 75.95%
- 69.60%
- 234.18%
- 237.06%
- 160.18%
- 42.65%
- 51.24%
- 58.78%
- 580.31%
- 2,040.33%
- -2,112.17%
Y/Y
118.41%
4.57%
8.36%
53.58%
1.23%
32.43%
17.37%
20.15%
14.71%
55.98%
251.59%
203.52%
Valuation
Enterprise Value
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Enterprise value
- $230.45 B
- $212.87 B
- $141.50 B
- $546.67 B
- $725.64 B
- $0.00
- $404.57 B
- $358.79 B
- $0.00
- $321.29 B
- $376.67 B
- $0.00
Y/Y
28.39%
7.63%
33.53%
51.1%
32.74%
100%
17.17%
11.32%
100%
5.83%
17.24%
100%
Enterprise value to Revenue
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Enterprise value to Revenue
- 3.87
- 3.35
- 2.26
- 16.02
- 16.11
- 0.00
- 4.75
- 4.04
- 0.00
- 5.92
- 6.69
- 0.00
Y/Y
20.65%
13.54%
32.41%
26.38%
0.56%
100%
22.2%
14.97%
100%
0.64%
13.04%
100%
Enterprise value to EBITDA
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Enterprise value to EBITDA
- 24.11
- 11.74
- 9.37
- 63.81
- 47.65
- 0.00
- 17.35
- 14.48
- 0.00
- 18.71
- 25.26
- 0.00
Y/Y
207.46%
51.3%
20.19%
52.74%
25.31%
100%
5.5%
16.54%
100%
32.56%
35.02%
100%
